Autoinflammatory associated vasculitis
Shira Ginsberg(Bnai Zion Medical Center), Doron Rimar(Technion – Israel Institute of Technology), Gleb Slobodin(Bnai Zion Medical Center), Abid Awisat(Bnai Zion Medical Center), Ofrat Beyar‐Katz(Rambam Health Care Campus), Karina Zilber(Bnai Zion Medical Center), Lisa Kaly(Bnai Zion Medical Center), Nizar Jiries(Bnai Zion Medical Center), M Rozenbaum(Bnai Zion Medical Center), Nina Boulman(Bnai Zion Medical Center), Itzhak Rosner(Bnai Zion Medical Center)
Cited by 10
Related Papers
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
|Blood Advances|2021|170
Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study
|Transplantation and Cellular Therapy|2021|164
Therapy-Educated Mesenchymal Stem Cells Enrich for Tumor-Initiating Cells
|Cancer Research|2018|103
Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell/CD19/CD22-negative acute lymphoblastic leukemia
|Leukemia|2019|69
Novel Approaches to Acute Myeloid Leukemia Immunotherapy
|Clinical Cancer Research|2018|63